NCT00909051View on ClinicalTrials.gov

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

CompletedOBSERVATIONAL
Enrollment

15,729

Participants

Timeline

Start Date

March 24, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Diabetes Mellitus
Interventions
DRUG

Acarbose (Glucobay, BAYG5421)

Patients with diabetes type 2 newly treated with Glucobay

Trial Locations (16)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY